|Videos|November 13, 2017

What Do PBMs, Health Plans Value When Selecting a Specialty Pharmacy Partner?

Elvin Montanez, PharmD, chief operations officer at BioPlus Specialty Pharmacy, discusses what pharmacy benefit managers look for in a specialty pharmacy.

Montanez: I think PBMs are really looking for specialty pharmacies that can be very nimble around their priorities. It varies with each payer and PBM platform. They may have a very different strategy or unique strategy that they’re looking for in 2017.

A specialty pharmacy that is very nimble around their strategies and is able to meet their value, as they define it, is very important.

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Latest CME

Virtual Event

Lung Cancer Day of Education 2026

Monday, October 26, 2026

Virtual Event

Specialty Pharmacy Day of Education 2026

Thursday, November 5, 2026

What Do PBMs, Health Plans Value When Selecting a Specialty Pharmacy Partner?

Related Content

Pharmacists as the Glue in Cardio-Kidney-Metabolic Care

Pharmacists Can Close the LDL Control Gap in Lipid Care

When Should Pharmacists Start Dual Antihypertensive Therapy?

Phase 3 Trial Shows Oral Deucrictibant Reduces Hereditary Angioedema Attacks by 83%

Desai: Screen HCM Patients for Sleep Apnea Aggressively

Latest CME

Lung Cancer Day of Education 2026

Specialty Pharmacy Day of Education 2026

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients

From Payload to Patient: Managing Toxicities of Antibody-Drug Conjugates Directed at HER2 and TROP2

Exploring Immunotherapy Strategies in Endometrial Cancer

Pharmacogenomics in Practice: Enhancing Patient Care Through Genetic Insights

New Oncology Therapy Approvals for 2025 (Pharmacist Credit)

New Horizons in ATTR-CM: Therapeutic Advances and Strategic Insights

Specialty Pharmacy Day of Education 2026

Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Pharmacists

Shingles Vaccination: Opportunities for Pharmacist Interventions to Provide Patient Education

Reducing Transfusion Burden in Myeloid Disorders: Novel Therapeutic Strategies and Pharmacist Interventions

The Pharmacist's Role in Palliative and End of Life Symptom Management (Pharmacy Technician Credit)

Panel Discussion: Integrating Novel Combinations and Earlier Line Use in Diffuse Large B-Cell Lymphoma

Optimizing Patient Outcomes in R/R DLBCL: Bridging Knowledge Gaps for Oncology Pharmacists in the Era of Novel Immunotherapies

Clinical Panel Debate: CAR T-Cell Therapy vs Bispecific Antibodies

The Pharmacist's Role in Palliative and End of Life Symptom Management

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients (Pharmacy Technician Credit)

Optimizing Antibody-Drug Conjugate Safety: Pharmacist Strategies for Grading, Monitoring, and Supportive Care

Directions in Oncology Pharmacy® 2026 Southeast

Transforming Generalized Myasthenia Gravis Care: The Evolving Role of Pharmacists in Optimizing Therapy and Long-Term Disease Management

Precision Matters: Foundations of Biomarker-Driven Care in Non-Small Cell Lung Cancer

Evolving Care in IgA Nephropathy: Translating Emerging Evidence Into Care

Navigating the Legal Landscape of Telehealth: Updates and Implications for Pharmacists and Technicians

From Testing to Treatment: Empowering Pharmacists to Overcome Barriers and Optimize Biomarker-Driven Care

Navigating the Legal Landscape of Telehealth: Updates and Implications for Pharmacists and Technicians (Pharmacy Technician Credit)

Exploring Oncolytic Viruses in Melanoma: Pharmacist-Led Approaches for Safe Integration

Clinical Presentation of Hyperglycemia with PI3K and AKT Inhibitors

Evolving Hidradenitis Suppurativa Management: Advancements in Treatment and Managed Care Integration Across Patient Populations

Reducing the Treatment Burden in HIV Management: The Pharmacist’s Role in Long-Acting Injectable Adoption

Optimizing Lipid Management in Statin-Intolerant Populations: Payer Strategies for Evidence-Based Access and Risk Reduction

Addressing Vaccine Hesitancy in Infectious Disease Prevention

Protecting Against Meningococcal Disease: Updates on Vaccines, Guidelines, and Pharmacist Best Practices

Targeting the Root of Autoimmunity in Generalized Myasthenia Gravis: Pharmacist Strategies for Integrating FcRn Therapies Into Specialty Practice

IL-23 Inhibitors in Psoriasis: Optimizing Access and Patient Outcomes Across Integrated Systems

Utilizing VMAT-2 Inhibitors for the Management of Tardive Dyskinesia: The Role of Long-Term Care Pharmacists

The Expanding Therapeutic Landscape in IgA Nephropathy: Translating New Clinical Evidence and Updated Guidelines Into Managed Care Strategies

The Expanding Therapeutic Landscape in IgA Nephropathy: A Case-Based Exploration of Optimized Patient Outcomes

Influenza Immunization in Older Adults: Enhanced Vaccines and Best Practices for Long-Term Care Pharmacists

From Guidelines to Action: Implementing Pneumococcal Vaccine ACIP Recommendations in Long-Term Care Settings

Directions in Oncology Pharmacy® 2026 Northeast

Directions in Oncology Pharmacy® 2026

Multidisciplinary Insights and Strategies for Patients Treated With PI3K and AKT Inhibitors to Prevent Hyperglycemia

Innovations in Retinal Therapies: A Managed Care Perspective on Anti-VEGF Advancements

Navigating Advanced Prostate Cancer Treatment: Optimizing Novel Therapeutic Strategies for Managed Care Pharmacists

Cardiorenal Protection With SGLT2 Inhibitors: Perspectives for Managed Care

Bridging Innovation and Access in HR-Positive/HER2-Negative Metastatic Breast Cancer: Implications for Managed Care

Effective Strategies to Manage Hyperglycemia When Treating with PI3K and AKT Inhibitors

An Eye on Access: Managed Care Perspectives in Demodex Blepharitis

Multidisciplinary Insights to Enhance Biomarker Testing Practices in Non-Small Cell Lung Cancer

Advancing Treatment Strategies in Extensive-Stage Small Cell Lung Cancer: Enhancing Pharmacist Competence in Therapy Selection, Administration, and Adverse Event Management

Transforming Gout Care: Navigating Barriers and Therapeutic Advances in Disease Management

Minimizing Injection Burden: Anti-VEGF Innovation for Retinal Disease Management

New Therapeutic Targets in the Treatment of Generalized Myasthenia Gravis: Understanding Disease Pathways and Pharmacist-Led Strategies for Optimized Care

Pharmacists at the Forefront: Enhancing Targeted Therapy Implementation and Patient Outcomes in Advanced Gastric Cancer

Managing Overactive Bladder in Older Adults: Challenges and Strategies for Long-Term Care

Bridging Clinical and Access Gaps in Phenylketonuria: A Managed Care Perspective

Biomarker Testing in Practice: Navigating Modalities and Multidisciplinary Decision-Making

Sugar, We’re Going Down: Navigating Glycemic Control in the Era of PI3K/AKT Inhibition for Breast Cancer

Advancing the Idiopathic Pulmonary Fibrosis Treatment Landscape: What’s Next in Care

Best Practice Approaches for Understanding Chronic Obstructive Pulmonary Disease and Precision Medicine Treatment

HER2-Positive Metastatic Breast Cancer: A Managed Care Perspective on Emerging Therapies and Clinical Data

Enhancing The Role of Oncology Pharmacists in Multidisciplinary Myeloproliferative Neoplasm Care

Optimizing Bispecific Antibody Therapy in Relapsed/Refractory Lymphomas: A Practical Guide for Pharmacists

An American Journal of Managed Care Forum: Bridging Evidence and Access in Advanced Small Cell Lung Cancer

The Educated Pharmacist: Overcoming Clinical Inertia—An Interactive Case Workshop for Optimizing Insulin Use

Two Targets, One Mission: Optimizing Bispecific Antibody Use in Non-Hodgkin Lymphoma

Advancing Chronic Kidney Disease Detection and Cardiovascular Risk Reduction in Complex Patients

Artificial Intelligence in Pharmacy Practice: Validated Tools, Real-World Applications, and Emerging Innovations (Pharmacy Technician Credit)

Artificial Intelligence in Pharmacy Practice: Validated Tools, Real-World Applications, and Emerging Innovations

Targeting the Complement Cascade: Evolving Strategies in the Management of Complement-Mediated Kidney Diseases

Hat Trick for Hypertension: Strategies to Improve Outcomes With Single-Pill Combinations